Literature DB >> 1913638

Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.

Y Shibamoto1, C Streffer.   

Abstract

We devised a new in vitro method to estimate the proportion of dividing cells and the potential doubling time (Tpot) of tumors using the same technique as with the cytokinesis-block micronucleus assay. The usefulness of this methodology was confirmed by comparing the data with those obtained by flow cytometry after bromodeoxyuridine (BrdUrd) incorporation. Xenografted human and murine tumors were excised 0.5-8 h after BrdUrd injection and disaggregated to single cells. A portion of these cells was then plated in dishes to which 1 or 2 micrograms/ml cytochalasin B were added. These concentrations of cytochalasin B blocked cytokinesis but not karyokinesis with the result that cells became multinucleate after mitoses. At every 12 or 24 h of culture, the proportion of multinucleate cells and the total number of nuclei and cells were scored. The remaining cells were analyzed with a flow cytometer and the BrdUrd-labeling index and Tpot were determined. In all 8 tumor lines studied, the proportion of multinucleate cells reached a plateau within 3-7 days of culture, and we therefore defined the dividing fraction as the plateau value. The dividing fraction ranged between 33 and 98% and clearly tended to be high in rapidly growing tumors. A significant correlation was seen between the dividing fraction and BrdUrd-labeling index (r = 0.74, P less than 0.001). The increase in the average number of nuclei per cell also tended to be higher in rapidly growing tumors. The Tpot was estimated as the time for this nucleus/cell ratio to reach 2.0. In 7 of 8 tumor lines, Tpot values estimated by this method compared reasonably with those estimated by the BrdUrd method. Therefore, this simple technique, originally developed for radiosensitivity prediction, would also seem to be useful in estimating tumor proliferative activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913638

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Otsuka; Hiromitsu Iwata
Journal:  J Radiat Res       Date:  2013-12-17       Impact factor: 2.724

2.  Treatment of near-infrared photodynamic therapy using a liposomally formulated indocyanine green derivative for squamous cell carcinoma.

Authors:  Tetsuro Maruyama; Yasunori Akutsu; Akiko Suganami; Yutaka Tamura; Hiromichi Fujito; Tomoki Ouchi; Naoki Akanuma; Yuka Isozaki; Nobuyoshi Takeshita; Isamu Hoshino; Masaya Uesato; Taro Toyota; Hideki Hayashi; Hisahiro Matsubara
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

3.  Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation.

Authors:  R Murata; Y Nishimura; Y Shibamoto; M Hiraoka; M Abe
Journal:  Jpn J Cancer Res       Date:  1996-06

4.  Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay.

Authors:  Y Shibamoto; T Shibata; S Miyatake; Y Oda; T Manabe; G Ohshio; K Yagi; C Streffer; M Takahashi; M Abe
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.